Mattias Haggblom

Stock Analyst at Nordea Markets

(1.10)
# 3,869
Out of 5,099 analysts
2
Total ratings
50%
Success rate
-15%
Average return

Stocks Rated by Mattias Haggblom

Swedish Orphan Biovitrum AB (publ)
Oct 22, 2026
Downgraded: Hold
Price Target: n/a
Current: $477.40
Upside: -
AddLife AB (publ)
Sep 25, 2024
Downgraded: Hold
Price Target: kr 195.00
Current: kr 180.20
Upside: n/a